Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
Clinical trial NCT06905262 · RECRUITING
Trial details
- NCT number
- NCT06905262
- Sponsor
- National Cancer Institute, Naples
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-02
- Primary completion
- 2025-09-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.